Search by keywords: Connect with us Stay Informed. Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters. Newsletter Sign Up COVID-19: Information for Patients and Caregivers We're here for you, and continue to provide cancer care to new and current patients. Learn about our response to COVID-19.What you need to know 1721 News Items found In the Clinic The Truth Behind Four Natural Cancer “Cures” Tuesday, June 25, 2024 The internet is full of “miracle cures” for cancer and alleged surefire ways to prevent it, and well-meaning people may urge cancer patients to just tr... Into the Matrix: MSK’s Mara Sherman is Unlocking the Secrets of the Fibrotic Fortress that Surrounds and Protects Pancreatic Cancer Monday, June 24, 2024 Dr. Mara Sherman's lab at the Sloan Kettering Institute is “all pancreas, all the time.” Learn how her research program is illuminating interactions between cancer cells and the dense weave of fibrous cells that surrounds and protects pancreatic tumors. FDA Approves First Colorectal Cancer Treatment that Targets KRAS Gene Friday, June 21, 2024 The targeted therapy adagrasib received accelerated approved for colorectal cancer caused by a mutation called KRAS-G12C, when used in combination with the drug cetuximab. MSK investigators have led much of the research that resulted in this combined drug approval. Fasting Primes the Immune System’s Natural Killer Cells to Better Fight Cancer, New Study in Mice Finds Friday, June 14, 2024 Animal model research from MSK has shown for the first time that fasting can reprogram the metabolism of natural killer cells, helping them to survive in the harsh environment in and around tumors, while also improving their cancer-fighting ability. FDA Grants Accelerated Approval to Repotrectinib for Cancers with NTRK Fusions Thursday, June 13, 2024 The FDA has approved the targeted drug repotrectinib for patients 12 and older with tumors that carry gene changes called NTRK fusions. The trial that resulted in the approval was led by MSK investigators. MSK Earns Top Distinction for Pediatric Cancer Care From American College of Surgeons Thursday, June 13, 2024 Thanks to MSK’s expertise in treating young people with cancer, 16-year-old high school athlete Sammy is back to doing what he loves. 2023 MSK Giving Monday, June 10, 2024 In 2023, the MSK Giving community raised a record-breaking $1 billion — 100% of which will support our mission of ending cancer for life. A Message From MSK Leaders Selwyn M. Vickers and Scott Stuart Monday, June 10, 2024 The President and CEO and Chair of the Board at Memorial Sloan Kettering Cancer Center introduce the year's highlights in their introductory letter to the 2023 Annual Report. Education A New Breed of Cancer Fighters Monday, June 10, 2024 Read about a first-of-its kind PhD program that enables aspiring scientists to tackle tough cancer problems. Clinical Trials at MSK Aim To Reduce Side Effects of Cancer Treatment Monday, June 10, 2024 Learn how MSK is Improving patients’ quality of life with less toxic treatments. Pagination Load More Book traversal links for Newsroom Previous Newsroom Next Cody's Story: How the MSK Kids Rare Tumor Program Benefited a Teenager With Advanced Kidney Cancer